Quarterly report pursuant to Section 13 or 15(d)

Schedule of Stock Option Transactions (Details)

v3.24.1.1.u2
Schedule of Stock Option Transactions (Details)
shares in Thousands
 3 Months Ended
Mar. 31, 2024
USD ($)
$ / shares
shares
Option Indexed to Issuer's Equity [Line Items]  
Number of Shares Available for Grant, Ending 275
Total Options Outstanding, Ending 558
Share-Based Payment Arrangement, Option [Member]  
Option Indexed to Issuer's Equity [Line Items]  
Number of Shares Available for Grant, Beginning 275
Total Options Outstanding, Beginning 558
Weighted Average Exercise Price Outstanding, Beginning | $ / shares $ 10.57
Aggregate Intrinsic Value, Beginning | $
Number of Shares Available for Grant, Increase in authorized options
Total Options Outstanding, Increase in authorized options
Weighted Average Exercise Price, Increase in authorized options | $ / shares
Aggregate Intrinsic Value, Increase in authorized options | $
Number of Shares Available for Grant, Exercised
Total Options Outstanding, Exercised
Weighted Average Exercise Price, Exercised | $ / shares
Aggregate Intrinsic Value, Exercised | $
Number of Shares Available for Grant, Granted
Total Options Outstanding, Granted
Weighted Average Exercise Price, Granted | $ / shares
Aggregate Intrinsic Value, Granted | $ / shares
Number of Shares Available for Grant, Expired
Total Options Outstanding, Expired
Weighted Average Exercise Price, Expired | $ / shares
Aggregate Intrinsic Value, Expired | $
Number of Shares Available for Grant, Cancelled
Total Options Outstanding, Cancelled
Weighted Average Exercise Price, Cancelled | $ / shares
Aggregate Intrinsic Value, Cancelled | $
Number of Shares Available for Grant, Ending 275
Total Options Outstanding, Ending 558
Weighted Average Exercise Price, Ending | $ / shares $ 10.38
Aggregate Intrinsic Value, Ending | $